Australian Pharmaceutical Industries Ltd
ASX:API
Wall Street
Price Targets
API Price Targets Summary
Australian Pharmaceutical Industries Ltd
According to Wall Street analysts, the average 1-year price target for API is 1.53 AUD .
Revenue
Forecast
Revenue Estimate
Australian Pharmaceutical Industries Ltd
For the last 8 years the compound annual growth rate for Australian Pharmaceutical Industries Ltd's revenue is 3%. The projected CAGR for the next 2 years is -17%.
Net Income
Forecast
Net Income Estimate
Australian Pharmaceutical Industries Ltd
For the last 8 years the compound annual growth rate for Australian Pharmaceutical Industries Ltd's net income is -30%. The projected CAGR for the next 2 years is 410%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is API's stock price target?
Price Target
1.53
AUD
According to Wall Street analysts, the average 1-year price target for API is 1.53 AUD .
What is Australian Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
-17%
For the last 8 years the compound annual growth rate for Australian Pharmaceutical Industries Ltd's revenue is 3%. The projected CAGR for the next 2 years is -17%.
What is Australian Pharmaceutical Industries Ltd's Net Income forecast?
Projected CAGR
410%
For the last 8 years the compound annual growth rate for Australian Pharmaceutical Industries Ltd's net income is -30%. The projected CAGR for the next 2 years is 410%.